A new report, titled, “Non-Invasive Prenatal Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027” has been published by Transparency Market Research. As per the report, the global market for non-invasive prenatal testing was valued at US$ 1300 Mn in 2018 and is projected to register a CAGR of 16% during the forecast period.

Growing cases of Downs’ syndrome, increasing maternal age, and rising demand for early and non-invasive fetal testing procedures are likely to fuel the global non-invasive prenatal testing market, says the report. Furthermore, other factors influencing the market growth negatively are stringent regulatory guidelines, limitations of non-invasive prenatal testing, and availabilities of other alternatives which would likely to hamper the growth of the global market in the future.

Nonetheless, emerging non-invasive prenatal testing is anticipated provide an opportunity to the global market in the near future. Region wise, North America is anticipated to hold a leading share of the global non-invasive prenatal testing market in the next few years, while the market in Asia Pacific is expected to expand at a significant growth rate in the near future.

The report has segmented the global non-invasive prenatal testing market in terms of test type into Materni21, Harmony, Panorama, Verifi, NIFTY, and others. Among these, the MaterniT21 segment dominated the global non-invasive prenatal testing market in 2018 and it is likely to remain highly lucrative during the forecast period. As per the report, in the U.S,, Sequenom (which was presently a part of Labcorp) introduced MateriT21 back in 2011, the first NIPT solution in the U.S. MaterniT21 is able to identify trisomies and expanded tests may also explain sex chromosomes disabilities and some microdeletions. MaterniT21’s significant advantage is the less percentage error. Apart from MaternitT21, the Panorama segment held a significant share of the global non-invasive prenatal testing market, in terms of volume, in 2018.

On the basis of application, the global non-invasive prenatal testing market is divided into Microdeletions Symptoms, Trisomy, and others (Sex Chromosomes Disorders). Rising new cases of Down’s syndrome among live births in the U.S. is a major factor attributed to the dominating share held by the trisomy segment of the global market in 2018. The TMR report also profiles some of the leading players operating in the global non-invasive prenatal testing market to give a better competitive analysis of the market. These players include Berry Genetics, BGI, Laboratory Corporation of America Holdings, Agilent Technologies, Inc., Illumina, Inc, F. Hoffmann-La Roche Ltd, NATERA, INC., PerkinElmer Inc, Eurofins LifeCodexx AG, and IGENOMIX.

To request a brochure of the global non-invasive prenatal testing market, kindly fill the form on https://technews4all.com/request-form/.

About Us

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Details

Email: [email protected]
Website: www.technews4all.com